Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For GBDC
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Bad
0%
Leverage & Liquidity Balanced
50%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio 55.20 9.78 6.30
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -4.24 34.05 35.56
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 0.57 15.20 15.11
Cash 323.43 1.68 0.40
Capex 0.00 0.00 0.00
Free Cash Flow -9.23 0.88 0.96
Revenue -42.10 0.56 0.96
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin 120.40 1.70 0.77
Operating Margin 77.97 0.92 0.51
ROA 18.42 0.02 0.01
ROE 22.05 0.04 0.03
ROIC 0.27 0.01 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of GBDC is permitted for members.
5 Growth
The "Growth Entry" for the Focus of GBDC is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of GBDC is permitted for members.